• Ownership

Kate Haviland - Insider Trading & Ownership

Entity
Individual
Location
Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge, MA
Summary
The estimated net worth of Kate Haviland is at least $17.3M dollars as of April 3, 2025. Kate Haviland is the CHIEF EXECUTIVE OFFICER, Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $17.2M. Kate Haviland is the Director of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $98.5K.
All Insider Reports
All Insider Reports

Ownership of Kate Haviland

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp CHIEF EXECUTIVE OFFICER, Director $17.2M -$2.04M -10.6% Apr 1, 2025
BCAX Bicara Therapeutics Inc. Director $98.5K Sep 12, 2024
FULC Fulcrum Therapeutics, Inc. Director Jun 17, 2024

Insider Transactions Reported by Kate Haviland:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.